Get started
Author

Kim M. Smits

Observed names: K M Smits, K. M. Smits, K. Smits, K.M. Smits, Kim M Smits, Kim Smits, Smits, Kim, Smits, Kim M, Smits, Kim M.
Observed institutions: National Institutes of Health, Johns Hopkins University, Université de Bourgogne, Johns Hopkins Medicine, Maastricht University Medical Centre, Ghent University, Yale University, Maastricht University, CHU Dijon Bourgogne, National Institute on Alcohol Abuse and Alcoholism, Dongnam Institute of Radiological & Medical Sciences, Johns Hopkins Hospital, Maastro Clinic, Sidney Kimmel Comprehensive Cancer Center, University College London, Amsterdam UMC Location Vrije Universiteit Amsterdam
ORCID: 0000-0002-4629-4396
Observed ORCIDs: 0000-0002-4629-4396, 0000-0003-2097-0533
OpenAlex ID: A5065090758
Analysis of DNA methylation in cancer: location revisited
2018 · Alexander Koch, Sophie C. Joosten, et al. · Nature Reviews Clinical Oncology · 707
Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer
2009 · Sabine C. Glöckner, Mashaal Dhir, et al. · Cancer Research · 230
PDF
Lamin A/C Is a Risk Biomarker in Colorectal Cancer
2008 · Naomi D. Willis, Thomas R. Cox, et al. · PLoS ONE · 229
PDF
N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer
2009 · Veerle Melotte, Marjolein H. F. M. Lentjes, et al. · JNCI Journal of the National Cancer Institute · 216
Colorectal Cancer Epigenetics: Complex Simplicity
2011 · Manon van Engeland, Sarah Derks, et al. · Journal of Clinical Oncology · 199
GATA4 and GATA5 are Potential Tumor Suppressors and Biomarkers in Colorectal Cancer
2009 · Debby M.E.I. Hellebrekers, Marjolein H.F.M. Lentjes, et al. · Clinical Cancer Research · 199
PDF
Influence of SERTPR and STin2 in the serotonin transporter gene on the effect of selective serotonin reuptake inhibitors in depression: a systematic review
2004 · K M Smits, L J M Smits, et al. · Molecular Psychiatry · 177
Epigenetics in renal cell cancer: mechanisms and clinical applications
2018 · Sophie C. Joosten, Kim M. Smits, et al. · Nature Reviews Urology · 161
Decision support systems for personalized and participative radiation oncology
2016 · Philippe Lambin, Jaap Zindler, et al. · Advanced Drug Delivery Reviews · 154
PDF
Genomic and Epigenomic Integration Identifies a Prognostic Signature in Colon Cancer
2011 · Joo Mi Yi, Mashaal Dhir, et al. · Clinical Cancer Research · 146
PDF
The CpG island methylator phenotype in colorectal cancer: Progress and problems
2011 · Laura A.E. Hughes, Carolina A.J. Khalid-de Bakker, et al. · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · 127
A Let-7 MicroRNA SNP in the KRAS 3′UTR Is Prognostic in Early-Stage Colorectal Cancer
2011 · Kim M. Smits, Trupti Paranjape, et al. · Clinical Cancer Research · 97
PDF
Participation in colorectal cancer screening trials after first-time invitation: a systematic review
2011 · C. Khalid-de Bakker, D. Jonkers, et al. · Endoscopy · 93
A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis
2013 · C.C.J.M. Simons, L.A.E. Hughes, et al. · Annals of Oncology · 91
PDF
Prognostic Significance of Gremlin1 (GREM1) Promoter CpG Island Hypermethylation in Clear Cell Renal Cell Carcinoma
2009 · Iris J.H. van Vlodrop, Marcella M.L. Baldewijns, et al. · American Journal Of Pathology · 83
PDF
Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review
2020 · Tim C. de Ruijter, Frank van der Heide, et al. · Breast Cancer Research · 81
PDF
Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine
2015 · Philippe Lambin, Jaap Zindler, et al. · Acta Oncologica · 78
PDF
Genetic and Epigenetic Alterations in the von Hippel-Lindau Gene: the Influence on Renal Cancer Prognosis
2008 · Kim M. Smits, Leo J. Schouten, et al. · Clinical Cancer Research · 74
PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer
2016 · Judith van Loon, Aniek J.G. Even, et al. · Radiotherapy and Oncology · 65
Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients
2013 · Georgi Nalbantov, Bas Kietselaer, et al. · Radiotherapy and Oncology · 62
PDF
Serotonin transporter polymorphisms and the occurrence of adverse events during treatment with selective serotonin reuptake inhibitors
2007 · Kim Smits, Luc Smits, et al. · International Clinical Psychopharmacology · 62
A Four-Gene Promoter Methylation Marker Panel Consisting of GREM1, NEURL, LAD1, and NEFH Predicts Survival of Clear Cell Renal Cell Cancer Patients
2016 · Iris J.H. van Vlodrop, Sophie C. Joosten, et al. · Clinical Cancer Research · 61
PDF
Prognostic DNA Methylation Markers for Renal Cell Carcinoma: A Systematic Review
2017 · Sophie C Joosten, Ivette AG Deckers, et al. · Epigenomics · 57
PDF
The influence of 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene on treatment effect of selective serotonin reuptake inhibitors in depressive patients
2008 · Kim M. Smits, Luc J.M. Smits, et al. · Psychiatric Genetics · 52
Epigenetics in radiotherapy: Where are we heading?
2014 · Kim M. Smits, Veerle Melotte, et al. · Radiotherapy and Oncology · 46
PDF
Works count: 193
Citation count: 4,579
H-index: 36
I10-index: 59
Year
Topic
Type